Recent advances in the pathogenesis and treatment of osteoporosis
Open Access
- 1 December 2015
- journal article
- review article
- Published by Elsevier in Clinical Medicine
- Vol. 15 (6) , s92-s96
Abstract
Over recent decades, the perception of osteoporosis has changed from that of an inevitable consequence of ageing, to that of a well characterised and treatable chronic non-communicable disease, with major impacts on individuals, healthcare systems and societies. Characterisation of its pathophysiology from the hierarchical structure of bone and the role of its cell population, development of effective strategies for the identification of those most appropriate for treatment, and an increasing armamentarium of efficacious pharmacological therapies, have underpinned this evolution. Despite this marked progress, individuals who experience a fragility fracture remain under-treated in many areas of the world, and there is substantial need for investment both in secondary and primary prevention globally. In this brief article, we give an overview of the pathogenesis of osteoporosis, and summarise current and future approaches to its assessment and treatment.Keywords
This publication has 27 references indexed in Scilit:
- Osteoporosis in the European Union: medical management, epidemiology and economic burdenArchives of Osteoporosis, 2013
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013Maturitas, 2013
- Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: A population-based HR-pQCT studyJournal of Bone and Mineral Research, 2010
- Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional studyThe Lancet, 2010
- Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitusOsteoporosis International, 2009
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trialThe Lancet, 2005
- Bone mineral crystal sizeOsteoporosis International, 2003
- A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosisOsteoporosis International, 2003
- Epidemiology of fractures in England and WalesBone, 2001